Brief: Virpax Pharmaceuticals Reports 2021 Third Quarter Results
Nov 15 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS REPORTS 2021 THIRD QUARTER RESULTS
AND
RECENT DEVELOPMENTS
* VIRPAX PHARMACEUTICALS INC - AT SEPTEMBER 30, 2021, CO HAD
CASH
OF APPROXIMATELY $41.7 MILLION
* VIRPAX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.53
Source text for Eikon: ID:nBw4sp944a
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study